Trials / Unknown
UnknownNCT05344794
Relationship Between Serum N/OFQ and Brain-heart Syndrome
Relationship Between Serum N/OFQ and Cerebral Cardiac Syndrome After Stroke
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Zheng Guo · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Choosing the neurology patients in the Second Hospital of Shanxi Medical University, diagnosed with patients with cerebral syndrome into the experimental group; patients who did not have cerebral syndrome included in the control group, and all selected people had no intimate relationship with each other.Specimen collecting control group and the study group serum inflammatory factor IL-6, solvent peptide and catecholamine content. The difference between the two groups of data was observed.According to the literature, it is guess: The solitary peptide content of the experimental group will be higher than the control group, and is positively correlated with IL-6, catecholamine content.The difference was statistically significant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Enzyme-linked immunosorbent assay | Serum N/OFQ , IL-6 and NE levels were detected. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2023-09-30
- Completion
- 2023-10-31
- First posted
- 2022-04-25
- Last updated
- 2023-02-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05344794. Inclusion in this directory is not an endorsement.